Franz Recker

9.1k total citations
37 papers, 1.0k citations indexed

About

Franz Recker is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Franz Recker has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Franz Recker's work include Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Franz Recker is often cited by papers focused on Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Franz Recker collaborates with scholars based in Switzerland, Germany and Finland. Franz Recker's co-authors include Maciej Kwiatkowski, R Tscholl, Andreas Huber, Timo Piironen, Kim Pettersson, Sigrid Carlsson, Monique J. Roobol, Anssi Auvinen, Teuvo L.J. Tammela and Jonas Hugosson and has published in prestigious journals such as Cancer, The Journal of Urology and International Journal of Cancer.

In The Last Decade

Franz Recker

36 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franz Recker Switzerland 17 727 258 168 139 121 37 1.0k
M. Frank O’Brien United States 15 697 1.0× 226 0.9× 127 0.8× 229 1.6× 36 0.3× 29 885
S. Guérif France 16 1.0k 1.4× 237 0.9× 375 2.2× 107 0.8× 78 0.6× 65 1.5k
Albert El Hajj Lebanon 15 361 0.5× 209 0.8× 185 1.1× 132 0.9× 136 1.1× 78 747
Varun Mittal India 13 186 0.3× 115 0.4× 175 1.0× 146 1.1× 107 0.9× 47 655
John W. Colberg United States 18 548 0.8× 252 1.0× 108 0.6× 69 0.5× 110 0.9× 35 970
L. Cormier France 21 822 1.1× 406 1.6× 241 1.4× 116 0.8× 142 1.2× 90 1.3k
Victor Srougi Brazil 16 312 0.4× 324 1.3× 46 0.3× 103 0.7× 51 0.4× 86 783
S. Vincendeau France 20 912 1.3× 303 1.2× 144 0.9× 153 1.1× 240 2.0× 91 1.2k
Leona C. Han United States 15 573 0.8× 320 1.2× 143 0.9× 243 1.7× 74 0.6× 23 834
Jason Hafron United States 22 863 1.2× 348 1.3× 181 1.1× 231 1.7× 265 2.2× 117 1.3k

Countries citing papers authored by Franz Recker

Since Specialization
Citations

This map shows the geographic impact of Franz Recker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Recker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Recker more than expected).

Fields of papers citing papers by Franz Recker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz Recker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Recker. The network helps show where Franz Recker may publish in the future.

Co-authorship network of co-authors of Franz Recker

This figure shows the co-authorship network connecting the top 25 collaborators of Franz Recker. A scholar is included among the top collaborators of Franz Recker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz Recker. Franz Recker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wetterauer, Christian, Jan Ebbing, Cyrill A. Rentsch, et al.. (2021). Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies. Urologia Internationalis. 106(1). 83–89. 1 indexed citations
2.
Carlsson, Sigrid, Marianne Månsson, Sue Moss, et al.. (2019). Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?. European Urology. 75(6). 1015–1022. 13 indexed citations
3.
Randazzo, Marco, Andreas Huber, Rainer Grobholz, et al.. (2015). Differences among Men on Active Surveillance for Very Low-Risk Prostate Cancer Detected Through Population-Based versus Opportunistic Prostate-Specific Antigen-Screening. Urologia Internationalis. 94(3). 330–336. 1 indexed citations
4.
Randazzo, Marco, Andreas Huber, Rainer Grobholz, et al.. (2015). Is further screening of men with baseline PSA < 1 ng ml−1worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau). International Journal of Cancer. 137(3). 553–559. 9 indexed citations
5.
Randazzo, Marco, Andreas Huber, Rainer Grobholz, et al.. (2014). A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening. European Urology. 68(4). 591–597. 23 indexed citations
6.
Becker, Andreas, Daniel Seiler, Maciej Kwiatkowski, et al.. (2014). A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center. World Journal of Urology. 32(4). 891–897. 6 indexed citations
7.
Randazzo, Marco, Andreas Huber, Rainer Grobholz, et al.. (2014). Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau). World Journal of Urology. 33(8). 1189–1196. 16 indexed citations
8.
Kwiatkowski, Maciej, Marco Randazzo, Luis Kluth, et al.. (2014). Prostate cancer screening: and yet it moves!. Asian Journal of Andrology. 17(3). 437–437.
9.
Olkhov‐Mitsel, Ekaterina, Theodorus van der Kwast, Ken J. Kron, et al.. (2012). Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer. Epigenetics. 7(9). 1037–1045. 35 indexed citations
10.
Schröder, Fritz H., Jonas Hugosson, Sigrid Carlsson, et al.. (2012). Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). European Urology. 62(5). 745–752. 182 indexed citations
11.
Seiler, Daniel, Marco Randazzo, Stephan Bauer, et al.. (2012). 995 DOES ACTIVE SURVEILLANCE LEAD TO INCREASED DISTRESS AND ANXIETY IN PARTNERS OF PROSTATE CANCER PATIENTS? DATA OF THE SWISS ERSPC-CENTER. The Journal of Urology. 187(4S). 1 indexed citations
12.
Seiler, Daniel, Marco Randazzo, Laurence Klotz, et al.. (2011). Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol‐based active surveillance: results from a contemporary European patient cohort. British Journal of Urology. 110(2). 195–200. 18 indexed citations
13.
Recker, Franz, et al.. (2009). PSA-Screening verringert Sterblichkeit um 20%. Bulletin des Médecins Suisses. 90(13). 514–514. 1 indexed citations
14.
Stephan, Carsten, Hellmuth‐Alexander Meyer, Maciej Kwiatkowski, et al.. (2006). A (-5, -7) ProPSA Based Artificial Neural Network to Detect Prostate Cancer. European Urology. 50(5). 1014–1020. 30 indexed citations
15.
Lein, Michael, Maciej Kwiatkowski, Axel Semjonow, et al.. (2003). A Multicenter Clinical Trial On the Use of Complexed Prostate Specific Antigen in Low Prostate Specific Antigen Concentrations. The Journal of Urology. 170(4 Part 1). 1175–1179. 36 indexed citations
16.
Recker, Franz, Maciej Kwiatkowski, Timo Piironen, et al.. (2000). Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen. Urology. 55(4). 481–485. 69 indexed citations
17.
Recker, Franz, Maciej Kwiatkowski, Kim Pettersson, et al.. (1998). Enhanced Expression of Prostate-Specific Antigen in the Transition Zone of the Prostate. European Urology. 33(6). 549–555. 17 indexed citations
18.
19.
Goepel, Μ., Franz Recker, T. Otto, S. Krege, & H. Rübben. (1996). Results of Postchemotherapy Adjunct ive Retroperitoneal Lymph Node Dissection in IMon-Seminomatous Germ Cell Cancer Patients. Urologia Internationalis. 57(4). 209–212. 4 indexed citations
20.
Kindler, Jochen, et al.. (1988). REGRESSION OF AN ADENOCARCINOMA TRANSMITTED BY A CADAVER KIDNEY GRAFT. Transplantation. 46(5). 777–778. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Frank O’Brien Breakdown of academic impact, for papers by S. Guérif Breakdown of academic impact, for papers by Albert El Hajj Breakdown of academic impact, for papers by Varun Mittal Breakdown of academic impact, for papers by John W. Colberg Breakdown of academic impact, for papers by L. Cormier Breakdown of academic impact, for papers by Victor Srougi Breakdown of academic impact, for papers by S. Vincendeau Breakdown of academic impact, for papers by Leona C. Han Breakdown of academic impact, for papers by Jason Hafron
Rankless by CCL
2026